Tsukamoto, Y., Natsumeda, M., Okada, M., Eda, T., Yoshimura, J., Okamoto, K., . . . Fujii, Y. (2019). COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA. Neurooncol Adv.
Chicago ZitierstilTsukamoto, Yoshihiro, Manabu Natsumeda, Masayasu Okada, Takeyoshi Eda, Junichi Yoshimura, Kouichirou Okamoto, Makoto Oishi, und Yukihiko Fujii. "COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA." Neurooncol Adv 2019.
MLA ZitierstilTsukamoto, Yoshihiro, et al. "COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA." Neurooncol Adv 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.